Inventor · disambiguated record
Nicholas Pagano
Also filed as: PAGANO NICHOLAS · PAGANO NICHOLAS J
6 granted patents·5 pending applications·30 citations·filing 1981–2025
77Inventor score
Top patents by PatentIndex Score
11 records- 0180US11033539B2Compounds of formulas (VII), (VIII), (IX), (XI), (XII), (XIII), and (XIV) as muscarinic receptor 4(M4) antagonists for treating neurological diseasesNEUROCRINE BIOSCIENCES INC·Filed 2016·Granted Jun 15, 2021·2 cites·17 claims
- 0274US11718618B2Substituted pyrido[2,1-a]isoquinolines as VMAT2 inhibitorsNEUROCRINE BIOSCIENCES INC·Filed 2023·Granted Aug 8, 2023·0 cites·28 claims
- 0370US2024010647A1SUBSTITUTED PYRIDO[2,1-a]ISOQUINOLINES AS VMAT2 INHIBITORSNEUROCRINE BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 0465US2025333413A1SUBSTITUTED PYRIDO[2,1-a]ISOQUINOLINES AS VMAT2 INHIBITORSNEUROCRINE BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 0559US2021338653A1N-[2-(1 -benzylpiperidin-4-yl)ethyl]-4-(pyrazin-2-yl)-piperazine-1 -carboxamide derivatives and related compounds as muscarinic receptor 4 (m4) antagonists for treating neurological diseasesNEUROCRINE BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 0658US6627296B1Elastically collapsible radome structureUS AIR FORCE·Filed 2000·Granted Sep 30, 2003·18 cites·4 claims
- 0752US2025092022A1Muscarinic receptor 4 antagonists and methods of useNEUROCRINE BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 0845US2023129359A1Muscarinic receptor 4 antagonists and methods of useNEUROCRINE BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 0944US12486250B2Muscarinic receptor 4 antagonists and methods of useNEUROCRINE BIOSCIENCES INC·Filed 2020·Granted Dec 2, 2025·0 cites·2 claims
- 1041US4359190AExact involute ply patternsUS AIR FORCE·Filed 1981·Granted Nov 16, 1982·10 cites·12 claims
- 1133US9120787B2HIV replication inhibitorsHEIL MARINTHA L·Filed 2012·Granted Sep 1, 2015·0 cites·19 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →